Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

26.7%

4 terminated/withdrawn out of 15 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

3 trials in Phase 3/4

Results Transparency

75%

6 of 8 completed trials have results

Key Signals

1 recruiting6 with results

Enrollment Performance

Analytics

N/A

8(72.7%)

Phase 4

3(27.3%)

11Total

N/A(8)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT05564494Not ApplicableRecruiting

Surgical Treatment of Recurrent Shoulder Dislocations

Role: collaborator

NCT04196218Not ApplicableNot Yet Recruiting

Driving After Shoulder Surgery

Role: lead

NCT02767492Not ApplicableCompleted

Steroid Injection vs. BioDRestore for Patients With Knee OA

Role: lead

NCT03995290Terminated

3D Modeling to Improve Hip Arthroscopy Outcomes

Role: lead

NCT03840096Not ApplicableCompleted

Effectiveness of BREG Flex in 12-week Peri-operative Total Knee Arthroplasty

Role: lead

NCT02350647Not ApplicableCompleted

Suture Anchor Comparison in Rotator Cuff Repairs

Role: lead

NCT03961711Not ApplicableCompleted

Telemedicine in Total Hip Arthroplasty and Total Knee Arthroplasty

Role: lead

NCT01937559Phase 4Completed

Topical Tranexamic Acid (TXA) in Joint Arthroplasty

Role: lead

NCT01937624Completed

Pediatric Distal Radius US Study

Role: lead

NCT02365961Phase 4Completed

Hip Scope Fascia-iliaca (FI) Block Study

Role: lead

NCT01256788Not ApplicableTerminated

Post-op Treatment With Hyaluronic Acid Injections

Role: lead

NCT01937403Completed

Sport Cord Test Following ACL Reconstruction

Role: lead

NCT01937572Not ApplicableTerminated

Visionaire: A Prospective Study

Role: lead

NCT02434913Unknown

HUD: PIP Joint Implant

Role: lead

NCT02365727Phase 4Withdrawn

Exparel vs Exparel Plus ACB in TKAs

Role: lead

All 15 trials loaded